Moreover, ETBR is overexpressed in vulvar cancer [5], clear-cell renal cell carcinoma [6], and esophageal squamous cell carcinoma [7] and is closely associated with disease progression and poor patient survival [5–7]. Here, EDNRB is linked to esophageal squamous cell carcinoma.